(c) 2021 PillSync.com

Ranexa 12 HR ranolazine 1000 MG Extended Release Oral Tablet Ranexa

1 INDICATIONS AND USAGE RANEXA ® is indicated for the treatment of chronic angina. RANEXA may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. RANEXA is an antianginal indicated for the treatment of chronic angina. ( 1 )

Gilead Sciences, Inc.


COVID-19 Cases Near You

Bitcoin Booming in Financial Crisis

Lowest Fees to Buy Crypto

Go PRO to remove this ad
5 years ago OVAL YELLOW GSI1000 Ranexa  12 HR ranolazine 1000 MG Extended Release Oral Tablet Ranexa

OVAL YELLOW GSI1000

5 years ago OVAL YELLOW GSI1000 Ranexa  12 HR ranolazine 1000 MG Extended Release Oral Tablet Ranexa

GSI1000 OVAL YELLOW

16 HOW SUPPLIED/STORAGE AND HANDLING RANEXA is supplied as film-coated, oblong-shaped, extended-release tablets in the following strengths: 500 mg tablets are light orange, with GSI500 on one side 1000 mg tablets are pale yellow, with GSI1000 on one side RANEXA (

RANOLAZINE) extended-release tablets are available in: Strength NDC Unit-of-Use Bottle (60 Tablets) 500 mg 61958-1003-1 Unit-of-Use Bottle (60 Tablets) 1000 mg 61958-1004-1 Store RANEXA tablets at 25°C (77°F) with excursions permitted to 15° to 30°C (59° to 86°F).

More pills like OVAL GSI1000












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site